Incruse Ellipta and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Incruse Ellipta and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Pneumococcal Conjugate Vaccine (7-Valent)
- Incruse Ellipta-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Incruse Ellipta-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Incruse Ellipta-Pneumovax 23
- Incruse Ellipta-PNV - Omega
- Incruse Ellipta-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Indacaterol
- Pneumococcal Conjugate Vaccine (13-Valent)-Indacaterol and Glycopyrrolate
- Pneumococcal Conjugate Vaccine (13-Valent)-Indacaterol and glycopyrrolate Inhalation
- Pneumococcal Conjugate Vaccine (13-Valent)-Indacaterol inhalation
- Pneumococcal Conjugate Vaccine (13-Valent)-Indacaterol Maleate
- Pneumococcal Conjugate Vaccine (13-Valent)-Indapamide